The biotech, which is co-run by ex Assistant US Health Secretary Brett Giroir, will progress its COPD-centric anti-rhinoviral ...

Boehringer Ingelheim India has signed a Memorandum of Understanding (MoU) to enhance pharmaceutical education and research ...

MSD and Mayo Clinic have entered a R&D collaboration to use AI, advanced analytics, and clinical data in support of drug ...

Following a difficult year that saw Ixchiq’s license suspended in the US, Valneva is pinning hopes on upcoming pipeline ...

Syngene International has entered a strategic collaboration with VivaMed BioPharma to advance AI-derived repurposed therapeutic programmes.

Novartis has signed a research partnership and licensing agreement with Unnatural Products (UNP) valued at up to $1.7bn.

The European Commission (EC) has approved a higher dose of Novo Nordisk’s Wegovy (semaglutide), marking a win for the ...

Analysis by WHO estimates that 6.2 million lives could be saved if next-generation vaccines are used through to 2050.

Industry and US administration leaders lay out their plans to navigate a globally competitive pharma landscape with China’s ...

J&J has received the US FDA approval for a new monthly dosing schedule for the combination therapy Rybrevant Faspro to treat ...

As theranostic radiopharmaceuticals gain prevalence, companies must overcome associated regulatory, manufacturing and ...

J&J's Pennsylvania cell therapy manufacturing site is one of four US-based facilities the company plans to build over the next four years.